Quest 10 Wealth Builders’s Bristol-Myers Squibb BMY Stock Holding History

Quest 10 Wealth Builders’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$6.28K	Buy	109 +7	+7%	+$402	﹤0.01%	514
2026 Q1	$6.19K	Buy	102 +18	+21%	+$1.05K	0.01%	501
2025 Q4	$4.51K	Sell	84 -1	-1%	-$48	﹤0.01%	508
2025 Q3	$3.82K	Sell	85 -30	-26%	-$1.4K	﹤0.01%	529
2025 Q2	$5.31K	Sell	115 -25	-18%	-$1.23K	0.01%	482
2025 Q1	$8.52K	Sell	140 -2	-1%	-$117	0.01%	386
2024 Q4	$8.03K	Buy	+142	New	+$7.93K	0.01%	426

Other funds holding BMY

LMFP

Larry Mathis Financial Planning Phoenix, Arizona $124B AUM

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

AIM

Artemis Investment Management Edinburgh, United Kingdom $11.2B AUM 80.72% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

FWIA

Fort Washington Investment Advisors Cincinnati, Ohio $19.9B AUM 22.19% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

DLA

Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return

Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return

Quest 10 Wealth Builders's BMY Position: Q2 2026 in Review

Quest 10 Wealth Builders increased its Bristol-Myers Squibb (BMY) stake by 6.9% in Q2 2026, buying an estimated $402 and bringing the position to 109 shares worth $6.28K. The position accounts for ﹤0.01% of the portfolio, ranked #514.

Quest 10 Wealth Builders first reported a position in BMY in Q4 2024 and has held it in 7 quarters since. The position peaked at $8.52K in Q1 2025. 796 funds tracked by Wall St. Rank hold BMY as of Q2 2026.

Quest 10 Wealth Builders held 109 shares of Bristol-Myers Squibb worth $6.28K as of Q2 2026.
Quest 10 Wealth Builders bought 7 Bristol-Myers Squibb shares in Q2 2026, an estimated $402.
Bristol-Myers Squibb made up ﹤0.01% of Quest 10 Wealth Builders's portfolio in Q2 2026, its #514 holding.
Quest 10 Wealth Builders first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 7 quarters since.
Quest 10 Wealth Builders's Bristol-Myers Squibb position peaked at $8.52K in Q1 2025.
796 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.

Based on Quest 10 Wealth Builders's 13F filing for Q2 2026, filed 24 Jul 2026.